Indian Pharma is likely to be in the top 10 global markets in value term
by 2020, according to the PwC – CII report titled “India
Pharma Inc: Gearing up for the next level of growth”.
The first pharmaceutical manufacturing company in India was started in 1930 in Kolkata (Calcutta) named as Bengal chemicals and pharmaceutical works which is still one of the 5 government owned company.
Indian
pharmaceutical market has characteristic of brand generic domination i.e.
around 70-80 % of retail market and low price level due to highly competitive
market. India has globally 10th rank in terms of value and 3rd
in terms of volumes. India is the
largest provider of generic drugs globally and accounts for supplies over 50 %
of global demand for various vaccines, 40 % of generic demand in the US and 25
% of all medicine in UK.
India has an
important position in the global pharmaceuticals sector with large pool of
talented scientists and engineers who have the potential to steer the industry
ahead. Presently over 80 % of the antiviral drugs used globally to combat
AIDS (Acquired Immune Deficiency Syndrome) are supplied by Indian
pharmaceutical firms.
The pharma profession started in India
simultaneously with inception in United Nation but the growth in India remained
very slow. For almost half a century not much progress was noticed, until
B.Pharm course was started in 1937 at Banaras Hindu University and in 1944 at
the Punjab University, Lahore. The pharmacist
plays a vital role and acts as a key chain between a physician and the patient.
According to Drugs and Cosmetic Act and Pharmacy act, a pharmacist is must-
anywhere and everywhere the medicine is there. Pharmacists are the only
authorized professionals who can handle medicines at all levels. After a
doctor, the pharmacists are the only professionals in the health sector who
play key role in patient safety program, clinical research as well drug
compounding and manufacturing. In India the pharma course is driven in the form
D.Pharm, B.pharm, M.pharm and also Pharm.D. Student can opt for PhD.
In
India there are more than 10, 00,000 (Ten Lakhs) registered pharmacists working
in various positions contributing to the health of the nation. But hurdle
took place when there is lack of proper respect and recognition of pharmacy
teachers, pharmacist in hospitals and industries. They also lack in the
step that B.Pharm must be preferential qualification for pharmacist but
presently D.Pharm is the essential qualification. This demotivates the
bachelor as well as master candidates to choose government pharmacist as a
career. There is need to recognize their efforts and to rationalize their
contribution toward healthcare.
Career prospective in Indian pharma precepts wide
variety of field i.e. from manufacturing process to Information Technology.
Indian pharma field provides multi angular professional diversity for the
pharmacy students to choose their career as per their choice. Various fields
are their like:
·
Research
and Development.
·
Pharmaceutical
Production.
·
Quality
analyst.
·
Packaging
technology
·
Clinical
research operation.
·
Clinical
Data management, medical coding, medical writing.
·
Regulatory
Affairs.
·
Pharmacovigilance
(booming currently).
Students as
well as in field professional should also focus on the technology trend which is
bringing transition and also transforming the pharma operation at new level.
Emerging data science and business analytics is helping healthcare sector to
boost their sales as well as forming more safe therapeutics. It is also helping
in understanding disease behavior which plays important role in the chronic
disease management like diabetes, cancer, cardiac arrest. People should also
focus learning some computer technology based program like R, Python, SAS. There
are also career building field where pharma student can apply ie intellectual
property right, Patent agent, and ISO agent.
Future Perception
As India is significant contributor towards world’s health care sector, Pharmaceutical industry has very good scope. Since India also ranks for the population there is also wide scope for clinical research industry. High burden of disease, good economic growth leading to higher disposable incomes, improvements in healthcare infrastructure and improved healthcare financing are driving growth in the domestic market. The Indian pharma industry has been growing at a annual growth rate of more than 15% over the last five years. However, for the industry to sustain this robust growth rate till 2020, companies will have to rethink their business strategy.
As India is significant contributor towards world’s health care sector, Pharmaceutical industry has very good scope. Since India also ranks for the population there is also wide scope for clinical research industry. High burden of disease, good economic growth leading to higher disposable incomes, improvements in healthcare infrastructure and improved healthcare financing are driving growth in the domestic market. The Indian pharma industry has been growing at a annual growth rate of more than 15% over the last five years. However, for the industry to sustain this robust growth rate till 2020, companies will have to rethink their business strategy.


